BamSEC and AlphaSense Join Forces
Learn More

Cognition Therapeutics Inc.

NASDAQ: CGTX    
Share price (12/20/24): $0.63    
Market cap (12/20/24): $26.2 million

Material Contracts Filter

EX-10.1
from 8-K 5 pages Cognition Therapeutics, Inc. 2021 Equity Incentive Plan Performance Restricted Stock Unit Grant Notice and Award Agreement
12/34/56
EX-10.1
from 8-K 11 pages Executive Employment Agreement
12/34/56
EX-10.2
from 8-K 15 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 39 pages Purchase Agreement
12/34/56
EX-10.1
from 8-K 49 pages Cognition Therapeutics, Inc. Shares of Common Stock (Par Value $0.001 Per Share) Controlled Equity Offeringsm Sales Agreement
12/34/56
EX-10.29
from S-1 47 pages Office Lease Agreement Between Rj Equities LP (Landlord) and Cognition Therapeutics, Inc. (Tenant) Dated: August 31, 2022
12/34/56
EX-10.12
from S-1/A 9 pages Cognition Therapeutics, Inc. 2021 Employee Stock Purchase Plan
12/34/56
EX-10.11
from S-1/A 15 pages Cognition Therapeutics, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.24
from S-1/A 5 pages 2. Duties; Time Commitment. as an Outside Director, You Will Be Expected to Attend the Meetings of the Board of Directors and the Committees of the Board on Which You Serve. It Is Contemplated That the Board Will Meet in Person Three Times a Year and by Telephone Three Times a Year and May Hold Special Meetings From Time to Time, Either in Person or by Telephone. It Is Also Contemplated That You Will Be Appointed Certain Committees of the Board, to Be Discussed at an Upcoming Board Meeting. It Is Anticipated That Each Committee of the Board Will Meet Four Times a Year and as Otherwise Needed. Board Meetings Are Scheduled Upon Prior Consultation With Directors and Are Typically Held in New York, Ny. the Next Board Meeting Is Currently Scheduled for September 16, 2020. 3. Compensation. A. Annual Retainer. for So Long as You Continue to Serve as a Director of the Company, and Subject to Approval by the Board, You Shall Be Entitled to Receive an Annual Retainer of $50,000, Payable on a Quarterly Basis. Such Retainer Shall Be Pro-Rated for Any Partial Year
12/34/56
EX-10.23
from S-1/A 4 pages 2. Duties; Time Commitment. as an Outside Director, You Will Be Expected to Attend the Meetings of the Board of Directors and the Committees of the Board on Which You Serve. It Is Contemplated That the Board Will Meet in Person Three Times a Year and by Telephone Three Times a Year and May Hold Special Meetings From Time to Time, Either in Person or by Telephone. It Is Also Contemplated That You Will Be Appointed Certain Committees of the Board, to Be Discussed at an Upcoming Board Meeting. It Is Anticipated That Each Committee of the Board Will Meet Four Times a Year and as Otherwise Needed. Board Meetings Are Scheduled Upon Prior Consultation With Directors and Are Typically Held in New York, Ny. the Next Virtual Board Dinner Is Currently Held Virtually and Is Scheduled for November 1, 2020 From 4 to 6pm Est. the Next Board Meeting Is Currently Scheduled for November 2, 2020, From 8:30am to 1 Pm Est. 3. Compensation. A. Annual Retainer. for So Long as You Continue to Serve as a Director of the Company, and Subject to Approval by the Board, You Shall Be Entitled to Receive an Annual Retainer of $50,000, Payable on a Quarterly Basis. Such Retainer Shall Be Pro-Rated for Any Partial Year
12/34/56
EX-10.22
from S-1/A 4 pages Cognition Therapeutics, Inc. 2021 Equity Incentive Plan Stock Option Grant Notice and Award Agreement
12/34/56
EX-10.21
from S-1/A 7 pages Employee Restrictive Covenant Agreement
12/34/56
EX-10.20
from S-1/A 10 pages Executive Employment Agreement
12/34/56
EX-10.16
from S-1/A 22 pages Executive Employment Agreement
12/34/56
EX-10.12
from S-1/A 9 pages Cognition Therapeutics, Inc. 2021 Employee Stock Purchase Plan
12/34/56
EX-10.11
from S-1/A 15 pages Cognition Therapeutics, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.1
from S-1/A 16 pages Indemnification Agreement
12/34/56
EX-10.34
from S-1 7 pages 19. Budget Period Start Date 05/01/2020 - End Date 05/31/2022 20. Total Amount of Federal Funds Obligated by This Action $ 0 20 A. Direct Cost Amount $ 0 20 B. Indirect Cost Amount $ 0 21. Authorized Carryover $ 0 22. Offset $ 0 23. Total Amount of Federal Funds Obligated This Budget Period $ 13,634,548 24. Total Approved Cost Sharing or Matching, Where Applicable $ 0 25. Total Federal and Non-Federal Approved This Budget Period $ 13,634,548 26. Project Period Start Date 09/15/2018 - End Date 05/31/2022 27. Total Amount of the Federal Award Including Approved Cost $ 30,482,877 Sharing or Matching This Project Period
12/34/56
EX-10.33
from S-1 6 pages Summary Federal Award Financial Information
12/34/56
EX-10.32
from S-1 8 pages Department of Health and Human Services National Institutes of Health National Institute on Aging Notice of Award Fain# Sb1ag073028 Federal Award Date 04/30/2021
12/34/56